Product Image

Boswellia 400 mg

Nature's Answer
4.7
★ ★ ★ ★ ★
(1643 ratings)
Boswellia 400 mg
Product Image
Score82
Boswellia 400 mg provides focused Boswellia support in a practical format. No boswellic-acid percentage, AKBA level, or absorption technology is disclosed, making potency difficult to compare.
How scoring works
Quantity:90 Capsule(s) • (90 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 82

Boswellia 400 mg provides focused Boswellia support in a practical format. No boswellic-acid percentage, AKBA level, or absorption technology is disclosed, making potency difficult to compare.
How scoring works
$23.99($0.26 per serving)
iHerb
$ 23.99
Pure Formulas
$ 24.44
Vitacost
$ 25.53
Amazon
$ 23.99
Report prices

Analysis

Each capsule provides 400 mg of Boswellia resin extract. The substantial serving and single-botanical design give the product a clear joint-comfort purpose at good practical value.

Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.

No boswellic-acid percentage, AKBA level, or absorption technology is disclosed, making potency difficult to compare. The 90-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.

Who is it for
  • Adults seeking an economical standalone Boswellia extract
  • People who prefer supplements in capsule form
  • Users who prefer a clearly focused botanical formula
Best for
  • Focused joint-comfort support
  • Normal inflammatory-response support
  • A routine with 90 servings per container

Pros

  • The substantial serving and single-botanical design give the product a clear joint-comfort purpose at good practical value
  • 90 servings per container
  • Single-ingredient design keeps the purpose clear

Cons

  • No boswellic-acid percentage, AKBA level, or absorption technology is disclosed, making potency difficult to compare.
  • Single-botanical scope does not cover cartilage structure or joint lubrication.
  • Capsule-only delivery may not suit people who avoid pills.

Warnings

  • Boswellia may add to bleeding tendency with anticoagulant or antiplatelet medicines, so this specific combination warrants medication review.
  • Count other Boswellia products when assessing total daily intake because the active boswellic-acid and AKBA yields may not be fully disclosed.
  • A new rash, digestive upset, or other persistent intolerance after starting Boswellia warrants stopping use and reassessing the product.

Nutrient quality

85 Highest impact

The practical extract amount and focused composition fit the intended use well. Missing active-acid standards and plain capsule delivery limit form quality.

Ingredient transparency

80 High impact

The extract amount is clear and no proprietary blend is used. Active strength, complete directions, and non-active ingredients remain undisclosed.

Customer satisfaction

72 High impact

The supplied average rating is strong and the rating volume is substantial. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

90 Highest impact

A useful extract amount at a favorable serving cost provides strong practical value. More complete potency specification would strengthen its position against standardized options.

Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A- Goal FitB Strength of SupportC CoverageA+ Formula Quality
Boswellia · 400 mg

Boswellia directly targets the 5-LOX pathway and is well aligned with inflammatory and joint-comfort support. The disclosed extract amount falls within a meaningful range.

Missing boswellic-acid standardization, AKBA content, and absorption support prevent a strong potency judgment. The single-botanical design is focused but does not cover oxidative or immune pathways.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
High effect
B+ Goal FitC+ Strength of SupportD+ CoverageA Formula Quality
Boswellia · 400 mg

Boswellia resin extract directly targets inflammatory pathways involved in joint discomfort and is well aligned with mobility support. Evidence is strongest for standardized extracts, but no boswellic-acid content is stated here.

The 400 mg amount is substantial for an extract, while missing standardization makes potency difficult to compare with studied products. The focused formula offers no cartilage building blocks or lubrication ingredients.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
Boswellia resin extract
400 mg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
Boswellia · 400 mg OverallScore57
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB- Value

The 400 mg extract amount fits the standard clinical range, but no boswellic acid or AKBA standardization is stated. The dry capsule provides no special absorption support. A low serving cost offers good practical value despite incomplete potency detail.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  2. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  3. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  4. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  5. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  6. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  7. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  8. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support Joint Health forBoswellia
  9. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health Anti-Inflammatory Support forBoswellia
  10. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  11. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  12. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  13. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  14. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study.
    Mamatha K; Prabhakaran P; Syam Das S; Kanjoormana Aryan M; Thomas J · Frontiers in pharmacology · 2025
    Randomized trial105 participantsAnti-Inflammatory Support forBoswellia
  15. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  16. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities.
    Efferth T; Oesch F · Seminars in cancer biology · 2022
    Systematic reviewAnti-Inflammatory Support forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia